Results of Proficiency Tests for HBsAg and Anti-HCV as the Blood Donor Screening Testing (2012~2015).
10.17945/kjbt.2016.27.3.265
- Author:
Mi Nam LEE
1
;
Jun Nyun KIM
;
Young Joo CHA
;
Qu Ehn PARK
;
Hyun Ok KIM
;
Gye Cheol KWON
;
Young Sill CHOI
;
Jeong Ran KWON
Author Information
1. The Division of Human Blood Safety Surveillance, Korea Centers for Disease Control and Prevention, Cheongju, Korea. drlord@korea.kr
- Publication Type:Original Article
- Keywords:
HBsAg;
Anti-HCV;
Proficiency test;
Blood center;
Donor screening test
- MeSH:
Academies and Institutes;
Blood Donors*;
Blood Safety;
Centers for Disease Control and Prevention (U.S.);
Donor Selection;
Hepacivirus;
Hepatitis B Surface Antigens*;
Humans;
Korea;
Mass Screening*
- From:Korean Journal of Blood Transfusion
2016;27(3):265-273
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
BACKGROUND: Donor screening test is one of the most important processes for blood safety management. Korea Center for Disease Control and Prevention (KCDC) has been conducting an annual proficiency test program that includes the distribution of specially manufactured panels for hepatitis B surface antigen (HBsAg) and antibody to hepatitis C virus (anti-HCV) to blood centers. Here, KCDC reports the results of these proficiency tests for HBsAg and anti-HCV blood donor screening for all licensed blood centers in Korea between 2012 and 2015. METHODS: Panels for the proficiency tests were manufactured and distributed to blood centers by Chung-Ang University Hospital, which has been participating in the Korea Blood Safety Commission. Well-proven reactive sera and healthy donor's sera acquired from the Human Serum Bank in Chung-Ang University were used to make the panels. To identify the S/CO ratio of the panel, three medical institutes triple-checked the results of each panel. RESULTS: Most blood centers reported correct answers for the proficiency test with six panels. The average percentages (year) of correct answers were as follows: 98.7% (2012), 98.5% (2013), 99.1% (2014) and 99.6% (2015) for the HBsAg proficiency tests; and 97.7% (2012), 99.5% (2013), 99.1% (2014), and 99.8% (2015) for the anti-HCV proficiency tests. CONCLUSION: To improve the blood center's ability for donor screening tests, KCDC will continue the proficiency test program by managing specialized panels for HBsAg and Anti-HCV tests. Furthermore, we will investigate the level of satisfaction to improve the quality of the program.
